Puregene takes the guesswork out of cannabis cultivation. With so much untapped potential, there will always be more to discover in this plant. Yet, by combining state-of-the art research, with our extensive cannabis experience, we can drive new variety development, tailoring yields to your specific needs.

Partner with us today to fast-track your progress and success.

Puregene has built one of the largest and most detailed data sets of cannabis characteristics. This, combined with our vast pangenomic sequencing platform and pipeline has allowed us to develop an unprecedented artificial intelligence-driven plant improvement program. Puregene uses predictive breeding instead of genetic modification.

Our approach rapidly guides correct combinations of characteristics to produce varieties tailored to the industries that they will serve. This will fundamentally alter the way in which plants are bred. Puregene’s 20-member R&D team has decoded over 400 individual cannabis characteristics that cover every aspect of its growth, development, and chemical composition. These are the building blocks for a next generation of cannabis with the potential to impact and disrupt myriad industries - pharmaceutical, cosmetic, animal feed, novel food, construction material and many more. On our journey, we aim to advance cannabis by broadly applying our genomic and artificial intelligence-driven approach to fundamentally change plant breeding. Puregene works with partners in Switzerland and globally to employ its cannabis research in support of the changing legal and health frameworks surrounding medical and recreational cannabis, to positively contribute to sustainability, to solve industrial challenges, and to educate the public, industry, and government on the potential of cannabis.

We are committed to improve cannabis genetics in the long-term for a positive future of this industry, innovating and developing what customers need and want.